drugset / Trial / NCT01221116
Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
RandomizedParallel-groupDouble-blindTreatment
Summary
Hypothesis: Treatment with levosimendan will preserve myocardial function and hemodynamics after cardiac surgery and lead to reduced stay at intensive care unit
Timeline
- Start
- 2003-01
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Levosimendan | Other / unclassified | 0.1 ug/kg | — |